150 related articles for article (PubMed ID: 23381074)
21. Proton pump inhibitors and risk of Clostridium difficile infection: association or causation?
Villafuerte-Gálvez JA; Kelly CP
Curr Opin Gastroenterol; 2018 Jan; 34(1):11-18. PubMed ID: 29095766
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitors: Clostridium difficile infections.
Prescrire Int; 2013 Oct; 22(142):239-40. PubMed ID: 24298587
[TBL] [Abstract][Full Text] [Related]
23. Response to Freedberg and Abrams.
Adler DG
Am J Gastroenterol; 2013 Feb; 108(2):279. PubMed ID: 23381078
[No Abstract] [Full Text] [Related]
24. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
25. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
Dial S; Delaney JA; Barkun AN; Suissa S
JAMA; 2005 Dec; 294(23):2989-95. PubMed ID: 16414946
[TBL] [Abstract][Full Text] [Related]
26. Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric Patients.
Brown KE; Knoderer CA; Nichols KR; Crumby AS
Clin Pediatr (Phila); 2015 Oct; 54(11):1102-6. PubMed ID: 25644650
[TBL] [Abstract][Full Text] [Related]
27. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
Kim YG; Graham DY; Jang BI
J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
[TBL] [Abstract][Full Text] [Related]
28. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
29. Reflux drugs linked to C. difficile-related diarrhea.
Kuehn BM
JAMA; 2012 Mar; 307(10):1014. PubMed ID: 22416090
[No Abstract] [Full Text] [Related]
30. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units.
Eastwood GM; Litton E; Bellomo R; Bailey MJ; Festa M; Beasley RW; Young PJ
Crit Care Resusc; 2014 Sep; 16(3):170-4. PubMed ID: 25161018
[TBL] [Abstract][Full Text] [Related]
31. Editorial: Clostridium difficile infection: Yet another predictor of poor outcome in cirrhosis.
Garcia-Tsao G; Surawicz CM
Am J Gastroenterol; 2010 Jan; 105(1):114-6. PubMed ID: 20054307
[TBL] [Abstract][Full Text] [Related]
32. Risk of Clostridium difficile-associated disease among patients receiving proton-pump inhibitors in a Quebec medical intensive care unit.
Beaulieu M; Williamson D; Pichette G; Lachaine J
Infect Control Hosp Epidemiol; 2007 Nov; 28(11):1305-7. PubMed ID: 17926283
[TBL] [Abstract][Full Text] [Related]
33. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic-associated pseudomembranous enteritis due to Clostridium difficile.
McBride M
Clin Infect Dis; 1995 Aug; 21(2):455. PubMed ID: 8562771
[No Abstract] [Full Text] [Related]
35. Fatal fulminant Clostridioides difficile colitis caused by Helicobacter pylori eradication therapy; a case report.
Nei T; Hagiwara J; Takiguchi T; Yokobori S; Shiei K; Yokota H; Senoh M; Kato H
J Infect Chemother; 2020 Mar; 26(3):305-308. PubMed ID: 31822448
[TBL] [Abstract][Full Text] [Related]
36. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.
Khanna S; Aronson SL; Kammer PP; Baddour LM; Pardi DS
Mayo Clin Proc; 2012 Jul; 87(7):636-42. PubMed ID: 22766083
[TBL] [Abstract][Full Text] [Related]
37. Does PPI therapy predispose to Clostridium difficile infection?
Pant C; Madonia P; Minocha A
Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):555-7. PubMed ID: 19713988
[TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile colitis: wash your hands before stopping the proton pump inhibitor.
Metz DC
Am J Gastroenterol; 2008 Sep; 103(9):2314-6. PubMed ID: 18924259
[TBL] [Abstract][Full Text] [Related]
39. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.
Freedberg DE; Lamousé-Smith ES; Lightdale JR; Jin Z; Yang YX; Abrams JA
Clin Infect Dis; 2015 Sep; 61(6):912-7. PubMed ID: 26060292
[TBL] [Abstract][Full Text] [Related]
40. Clostridium difficile infection and colonization.
Lapane KL; Motzkus-Feagans C; Pakyz A
N Engl J Med; 2012 Jan; 366(3):276; author reply 276-7. PubMed ID: 22256813
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
